Dawson James Downgrades Bluejay Diagnostics to Neutral
Portfolio Pulse from Benzinga Newsdesk
Dawson James analyst Jason Kolbert has downgraded Bluejay Diagnostics (NASDAQ:BJDX) from Buy to Neutral.

August 04, 2023 | 1:51 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Bluejay Diagnostics has been downgraded from Buy to Neutral by Dawson James, which could potentially impact the stock's performance.
Analyst ratings often influence investor sentiment and can impact a stock's price. A downgrade from Buy to Neutral suggests that the analyst sees less upside potential, which could lead to a decrease in demand for the stock and potentially lower prices in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100